menu
    • menu

    Company profile for ZielBio

    NEW Drugs in Dev: 1
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ZielBio is a clinical-stage pharmaceutical company with an innovative mindset. Drug discovery today, with its focus on genetic mutations and expression levels, is limited by an incomplete understanding of disease biology and the difficulty of identifying druggable disease targets. We recognize that the key to truly transformational therapies is the ability to discover new, actionable targets and this realization inspired our a...
    ZielBio is a clinical-stage pharmaceutical company with an innovative mindset. Drug discovery today, with its focus on genetic mutations and expression levels, is limited by an incomplete understanding of disease biology and the difficulty of identifying druggable disease targets. We recognize that the key to truly transformational therapies is the ability to discover new, actionable targets and this realization inspired our approach to drug discovery. Our proprietary platform, ZielFind, is designed with the end in mind. We reverse engineer the ideal therapy, leveraging ZielFind to reveal new insights into disease biology to design.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ZielBioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    705D Dale Avenue, Charlottesville, Virginia 22903
    Telephone
    Telephone
    (434) 202-7771
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.zielbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/zielbio-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ZielBio to Present Findings from its Phase 1/2, First-in-Human Trial of ZB131
    ZielBio to Present Findings from its Phase 1/2, First-in-Human Trial of ZB131

    02 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/zielbio-to-present-interim-findings-from-its-phase-12-first-in-human-trial-of-zb131-at-2023-asco-annual-meeting-301840821.html

    PR NEWSWIRE
    02 Jun 2023
    Share Share
    ZielBio to Present New Research Utility of Cancer-Specific Plectin (CSP) ZB131
    ZielBio to Present New Research Utility of Cancer-Specific Plectin (CSP) ZB131

    17 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/zielbio-to-present-new-research-on-the-utility-of-cancer-specific-plectin-csp-and-zb131-in-antibody-drug-conjugates-at-aacr-annual-meeting-2023-301798873.html

    PR NEWSWIRE
    17 Apr 2023
    Share Share
    ZielBio Appoints Alan Bash CEO as Company Advances Oncology Therapeutics
    ZielBio Appoints Alan Bash CEO as Company Advances Oncology Therapeutics

    03 Jan 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/zielbio-appoints-alan-bash-ceo-as-company-advances-oncology-therapeutics-301712159.html

    PR NEWSWIRE
    03 Jan 2023
    Share Share
    ZielBio Receives Orphan Drug Designation for ZB131 for Pancreatic Cancer
    ZielBio Receives Orphan Drug Designation for ZB131 for Pancreatic Cancer

    27 Dec 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/zielbio-receives-orphan-drug-designation-for-zb131-for-the-treatment-of-pancreatic-cancer-301709748.html

    PRNEWSWIRE
    27 Dec 2022
    Share Share
    ZielBio Receives Orphan Drug Designation for ZB131
    ZielBio Receives Orphan Drug Designation for ZB131

    15 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/zielbio-receives-orphan-drug-designation-for-zb131-for-the-treatment-of-cholangiocarcinoma-301678075.html

    PRNEWSWIRE
    15 Nov 2022
    Share Share
    ZielBio to Present New Data Demonstrating Preclinical Efficacy of ZB131
    ZielBio to Present New Data Demonstrating Preclinical Efficacy of ZB131

    12 Apr 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/zielbio-to-present-new-data-demonstrating-preclinical-efficacy-of-zb131-in-cholangiocarcinoma-at-aacr-annual-meeting-2022-301523511.html

    PRNEWSWIRE
    12 Apr 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search